DRKS00019928已完成不适用
Observational analysis of glycaemic, dietary and GPS data of Team Novo Nordisk Professional cyclists under race conditions
Applied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), A111 Engineering East, Fabian Way, Crymlyn Burrows0 个研究点目标入组 8 人开始时间: 2020年1月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- Male
入选标准
- •Informed consent obtained
- •- Male aged 18-65 years (both inclusive)
- •- Type 1 diabetes mellitus (as diagnosed clinically)
- •- Treated with multiple daily insulin injections = 12 months
排除标准
- •- Receipt of any investigational medicinal product within 1 month prior to screening in this trial
- •- Haemoglobin <8.0 mmol/L (male)
- •- Systemic (oral or i.v.) corticosteroids, monoamine oxidase (MAO) inhibitors, non-selective beta-blockers, growth hormone and non-routine vitamins and herbal products. Furthermore, thyroid hormones are not allowed unless the use of these has been stable during the past 3 months.
- •- Suffer from or history of a life-threatening disease (i.e. cancer judged not to be in full re-mission except basal cell skin cancer or squamous cell skin cancer), or clinically severe diseases that directly influence the study results, as judged by the Investigator. This does not prohibit the participation of patients taking medications that influences the metabolism (e.g. statin) or cardio-respiratory system (e.g. asthma spray) as long as the therapy is stable and is not adapted through-out the run of the trial. Furthermore, it does not exclude patients how have celiac disease (or similar diseases or allergies), as long as the disease is stable, and patients are able to stay on their specific (e.g.) gluten-free diet.
- •- Cardiac problems defined as decompensated heart failure (New York Heart Association (NYHA) class III and IV) 10 at any time and/or angina pectoris within the last 12 months and/or acute myocardial infarction at any time
- •- Supine blood pressure at screening (after resting for 5 min in supine position) outside the range of 90-140 mmHg for systolic or 50-90 mmHg for diastolic (excluding white-coat hypertension; therefore, if a repeated measurement on a second screening Visit shows values within the range, the participant can be included in the trial). This exclusion criterion also pertains to participants being on anti-hypertensives
- •- Clinically significant abnormal ECG issues, as judged by the Medical Team
- •- Severe retinopathy or maculopathy and/or severe neuropathy, in particular autonomic neuropathy, as judged by the Medical Team
- •- Any chronic disorder or severe disease which, in the opinion of the Medical Team might jeopardise participant’s safety or compliance with the protocol
- •- History of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction
- •- Significant history of alcoholism or drug/chemical abuse as per Investigator’s judgement or a positive result in the urine drug/alcohol screen at the screening Visit.
- •- Smoker (defined as a participant who is smoking more than 5 cigarettes or the equivalent per day)
- •- Not able or willing to refrain from smoking or use of nicotine substitute products during the monitoring period.
- •- Recurrent severe hypoglycaemia (more than 1 severe hypoglycaemic event requiring assistance during the past 6 months)
- •- Hypoglycaemic unawareness as judged by the Medical Team or hospitalisation for diabetic ketoacidosis during the previous 6 months
- •- Participant with mental incapacity or language barriers precluding adequate understanding or cooperation or who, in the opinion of their general practitioner or the Medical Team, should not participate in the trial
- •- Potentially non-compliant or uncooperative during the trial, as judged by the Medical Team
- •- Any condition that would interfere with trial participation or evaluation of results, as judged by the Medical Team
研究者
相似试验
已完成
不适用
Observational analysis of glycaemic, dietary and GPS data of Team Novo Nordisk Professional cyclists during a training campE10Type 1 diabetes mellitusDRKS00019923Applied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), A111 Engineering East, Fabian Way, Crymlyn Burrows16
已完成
不适用
Assessment of the glycemic responses to nutritional productsniet van toepassing10018424NL-OMON49247utricia Research10
招募中
不适用
Glycemic profiles assessment by continuous glucose monitoring in automated peritoneal dialysis patients.Glycemic control in end stage kidney disease patients who on automated peritoneal dialysisend stage kidney disease, automated peritoneal dialysis, peritoneal dialysis, continuous glucose monitoring, glycemic profile, time in range, diabetes mellitusTCTR20230826010Routine to Research, Faculty of medicine, Siriraj hospital30
尚未招募
不适用
Evaluation of Glycemic Variability and Hypoglycemic Episodes in type 2 Diabetics with Important Decrease of Renal FunctioRBR-8pd5zrPontifícia Universidade Católica do Paraná
招募中
不适用
Observational study of glycemic variability for the patients with diabetes mellitus during the perioperative period of curative gastrectomy for gastric cancerKCT0007676The Catholic University of Korea, St. Vincent's Hospital80